TMC Life Sciences Berhad Balance Sheet

Financials in millions MYR. Fiscal year is July - June.

Millions MYR. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	110.85	109.56	188.57	166.54	141.14	139.91
Short-Term Investments	-	2.07	2.56	2.15	2	1.25
Cash & Short-Term Investments	110.85	111.64	191.13	168.69	143.14	141.16
Cash Growth	-35.71%	-41.59%	13.30%	17.85%	1.40%	2.46%
Accounts Receivable	65.37	42.67	31.13	38.41	24.29	13.35
Other Receivables	10.35	28.91	25.57	29.15	24.18	18.57
Receivables	75.72	71.59	56.7	67.56	48.47	31.91
Inventory	16.63	15.91	11.62	13.37	10.88	10.3
Prepaid Expenses	-	3.35	3.09	2.17	2.06	2.31
Total Current Assets	203.19	202.48	262.54	251.8	204.55	185.68
Property, Plant & Equipment	721.1	725.78	718.27	715.15	728.45	677.33
Goodwill	-	193.05	193.05	193.05	193.05	193.05
Other Intangible Assets	200.08	8.15	13.45	12.55	1.68	1.9
Long-Term Deferred Tax Assets	0.7	0.7	0.32	2.09	2.91	-
Other Long-Term Assets	2.03	2.04	2.1	2.16	2.22	2.28
Total Assets	1,127	1,132	1,190	1,177	1,133	1,060
Accounts Payable	65.45	26.88	18.45	19.9	25.57	16.43
Accrued Expenses	-	13.28	20.19	22.06	15.74	10.71
Current Portion of Long-Term Debt	41.58	39.95	25.3	15.1	7.6	0.1
Current Portion of Leases	2.05	-	-	2.59	2.44	2.34
Current Income Taxes Payable	0.07	0.56	0.38	0.05	0.01	-
Current Unearned Revenue	0.51	0.52	0.53	-	-	-
Other Current Liabilities	-	29.13	33.78	38.87	38.93	45.87
Total Current Liabilities	109.65	110.31	98.62	98.57	90.28	75.45
Long-Term Debt	129.98	141.43	178.83	198.38	196.17	164.77
Long-Term Leases	2.24	1.6	1.1	2.99	4.24	7.39
Long-Term Unearned Revenue	0.34	0.36	0.26	-	-	-
Long-Term Deferred Tax Liabilities	26.69	24.72	22.66	14.41	14.39	22.64
Other Long-Term Liabilities	0.75	0.74	0.22	0.49	0.38	0.36
Total Liabilities	269.64	279.15	301.69	314.84	305.46	270.61
Common Stock	625.99	625.99	625.99	625.99	625.99	625.99
Retained Earnings	231.47	227.06	260.73	234.56	199.69	159.97
Comprehensive Income & Other	-	-	1.32	1.42	1.71	3.67
Shareholders' Equity	857.46	853.04	888.03	861.96	827.39	789.62
Total Liabilities & Equity	1,127	1,132	1,190	1,177	1,133	1,060
Total Debt	175.84	182.97	205.23	219.06	210.44	174.6
Net Cash (Debt)	-65	-71.33	-14.1	-50.37	-67.3	-33.45
Net Cash Per Share	-0.04	-0.04	-0.01	-0.03	-0.04	-0.02
Filing Date Shares Outstanding	1,742	1,742	1,742	1,742	1,742	1,742
Total Common Shares Outstanding	1,742	1,742	1,742	1,742	1,742	1,742
Working Capital	93.55	92.17	163.92	153.23	114.26	110.23
Book Value Per Share	0.49	0.49	0.51	0.49	0.47	0.45
Tangible Book Value	657.38	651.85	681.54	656.36	632.66	594.68
Tangible Book Value Per Share	0.38	0.37	0.39	0.38	0.36	0.34
Land	-	180	180	180	180	180
Buildings	-	357.94	357.74	355.3	353.21	62.37
Machinery	-	200.18	178.87	172.47	156.23	109.19
Construction In Progress	-	101.91	109.3	97.32	108.69	382.18

Source: S&P Global Market Intelligence. Standard template. Financial Sources.